EA201390403A1 - Способы получения фенилацетата l-орнитина - Google Patents
Способы получения фенилацетата l-орнитинаInfo
- Publication number
- EA201390403A1 EA201390403A1 EA201390403A EA201390403A EA201390403A1 EA 201390403 A1 EA201390403 A1 EA 201390403A1 EA 201390403 A EA201390403 A EA 201390403A EA 201390403 A EA201390403 A EA 201390403A EA 201390403 A1 EA201390403 A1 EA 201390403A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- phenylacetate
- methods
- ornitin
- obtaining
- ornithine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/32—Phenylacetic acid
Abstract
В изобретении предложены способы получения фенилацетата L-орнитина. Указанный способ может включать, например, смешивание галогенидной соли L-орнитина с фенилацетатом серебра. Способ также может включать получение фенилацетатной соли in situ.Заявка также относится к различным композициям, полученным согласно данным способам, содержащим кристаллические формы.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39058510P | 2010-10-06 | 2010-10-06 | |
PCT/US2011/054983 WO2012048043A1 (en) | 2010-10-06 | 2011-10-05 | Methods of making l-ornithine phenyl acetate |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201390403A1 true EA201390403A1 (ru) | 2013-09-30 |
EA028395B1 EA028395B1 (ru) | 2017-11-30 |
Family
ID=45928120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201390403A EA028395B1 (ru) | 2010-10-06 | 2011-10-05 | Способы получения фенилацетата l-орнитина |
Country Status (16)
Country | Link |
---|---|
US (2) | US8946473B2 (ru) |
EP (1) | EP2625162B1 (ru) |
JP (1) | JP6087284B2 (ru) |
KR (1) | KR101888215B1 (ru) |
CN (1) | CN103502203B (ru) |
AU (1) | AU2011312042B2 (ru) |
BR (1) | BR112013008054B1 (ru) |
CA (1) | CA2813563C (ru) |
EA (1) | EA028395B1 (ru) |
ES (1) | ES2720148T3 (ru) |
IL (1) | IL225512A (ru) |
MX (1) | MX360062B (ru) |
NZ (1) | NZ609191A (ru) |
SG (1) | SG189231A1 (ru) |
TR (1) | TR201903978T4 (ru) |
WO (1) | WO2012048043A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005019319D1 (de) | 2004-11-26 | 2010-03-25 | Ucl Business Plc | Zusammensetzungen mit ornithin und phenylacetat oder phenylbutyrat zur behandlung von hepatischer enzephalopathie |
MX2011010262A (es) * | 2009-04-03 | 2012-01-25 | Ocera Therapeutics Inc | Fenil acetato de l-ornitina y metodos para elaborar el mismo. |
DK2799067T3 (da) | 2009-06-08 | 2019-06-03 | Ucl Business Plc | Behandling af hjerneinflammation ved anvendelse af L-Ornithin-phenylacetat |
EA028395B1 (ru) * | 2010-10-06 | 2017-11-30 | Осера Терапьютикс, Инк. | Способы получения фенилацетата l-орнитина |
CA2968544A1 (en) | 2014-11-24 | 2016-06-02 | Ucl Business Plc | Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies |
JP2018513171A (ja) * | 2015-04-20 | 2018-05-24 | オセラ セラピューティクス, インコーポレイテッド | L−オルニチンフェニルアセテート製剤 |
CA2995823A1 (en) * | 2015-08-18 | 2017-02-23 | Ocera Therapeutics, Inc. | Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate |
US11219611B2 (en) | 2015-11-13 | 2022-01-11 | Ocera Therapeutics, Inc. | Formulations of L-ornithine phenylacetate |
BR112018009349A8 (pt) * | 2015-11-13 | 2019-02-26 | Ocera Therapeutics Inc | formulações de fenilacetato de l-ornitina |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
EP3621947A4 (en) * | 2017-05-11 | 2021-03-10 | Ocera Therapeutics, Inc. | L-ORNITHINE PHENYLACETATE MANUFACTURING PROCESSES |
CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB965637A (en) | 1962-04-23 | 1964-08-06 | Tanabe Seiyaku Co | L-ornithine l-aspartate |
NL302572A (ru) | 1962-12-27 | |||
GB1067742A (en) | 1963-09-16 | 1967-05-03 | Kyowa Hakko Kogyo Kk | Process for the preparation of l-ornithine l-aspartate |
ZA716628B (en) | 1970-10-15 | 1972-06-28 | Richardson Merrell Spa | Composition and method for treatment of hepatic disease and mental fatigue |
US4100293A (en) | 1974-04-15 | 1978-07-11 | The Johns Hopkins University | Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids |
US3950529A (en) | 1975-02-03 | 1976-04-13 | Massachusetts General Hospital | Amino acid formulations for patients with liver disease and method of using same |
US4228099A (en) | 1978-03-17 | 1980-10-14 | The Johns Hopkins University | Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders |
US4320146A (en) | 1978-03-17 | 1982-03-16 | The Johns Hopkins University | Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids |
US4352814A (en) | 1979-04-18 | 1982-10-05 | The Johns Hopkins University | Treatment of hepatic and renal disorders with mixed salts of essential or semi-essential amino acids and nitrogen-free analogs |
US4284647A (en) | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
US4457942A (en) | 1982-08-20 | 1984-07-03 | Brusilow Saul W | Process for waste nitrogen removal |
US5591613A (en) | 1990-07-02 | 1997-01-07 | Degussa Aktiengesellschaft | Method for the preparation of D-arginine and L-ornithine |
DE4020980C1 (ru) | 1990-07-02 | 1991-09-26 | Degussa Ag, 6000 Frankfurt, De | |
JP3127484B2 (ja) | 1991-02-28 | 2001-01-22 | 味の素株式会社 | 肝炎治療薬 |
US5767086A (en) | 1992-04-03 | 1998-06-16 | Terrapin Technologies, Inc. | Bone marrow stimulation by certain glutathione analogs |
JP3166123B2 (ja) | 1992-09-09 | 2001-05-14 | フアイソンズ・ピーエルシー | 薬剤パッケージング |
US5571783A (en) | 1993-03-09 | 1996-11-05 | Clintec Nutrition Company | Composition and method for treating patients with hepatic disease |
JP3273578B2 (ja) * | 1993-09-21 | 2002-04-08 | 第一化学薬品株式会社 | オルニチンと酸性アミノ酸類又はケト酸類との塩の製造法 |
US5856481A (en) | 1994-07-28 | 1999-01-05 | Syntex (U.S.A.) Inc. | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
AU2251897A (en) | 1996-02-13 | 1997-09-02 | Trustees Of The University Of Pennsylvania, The | Method of treating liver disorders |
ZA986614B (en) | 1997-07-25 | 1999-01-27 | Gilead Sciences | Nucleotide analog composition |
GB9815567D0 (en) | 1998-07-18 | 1998-09-16 | Glaxo Group Ltd | Antiviral compound |
US6258849B1 (en) | 1998-07-23 | 2001-07-10 | Stanislaw R. Burzynski | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
EP1179347A4 (en) | 1999-05-21 | 2002-06-26 | Takeda Chemical Industries Ltd | HEPATIC FUNCTION REGULATORS |
US6768024B1 (en) | 2000-08-04 | 2004-07-27 | Lion Bioscience Ag | Triamine derivative melanocortin receptor ligands and methods of using same |
JP3211824B1 (ja) | 2000-10-26 | 2001-09-25 | 味の素株式会社 | 分岐鎖アミノ酸含有医薬用顆粒製剤とその製造方法 |
DE60233558D1 (de) | 2001-03-15 | 2009-10-15 | Takashi Abe | Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber |
US6503530B1 (en) | 2001-11-01 | 2003-01-07 | Chunghee Kimberly Kang | Method of preventing development of severe metabolic derangement in inborn errors of metabolism |
US20030105104A1 (en) | 2001-11-27 | 2003-06-05 | Burzynski Stanislaw R. | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
US20040229948A1 (en) | 2002-04-12 | 2004-11-18 | Summar Marshall L. | Method for preventing hepatic encephalopathic episodes |
US20030195255A1 (en) | 2002-04-12 | 2003-10-16 | Summar Marshall L. | Method for treating hepatic encephalopathies |
CN1383815A (zh) | 2002-05-08 | 2002-12-11 | 刘万忠 | 防治肝病、肝性脑病的鸟氨酸和门冬氨酸的复方制剂及其制备方法 |
US20040152784A1 (en) | 2002-07-23 | 2004-08-05 | Special Products Limited | Pharmaceutical composition and method for treatment of a urea cycle deficiency or sickle-cell anaemia |
AU2003261825A1 (en) | 2002-08-30 | 2004-03-19 | Ajinomoto Co., Inc. | Therapeutic agent for hepatic disease |
US20050059150A1 (en) | 2003-09-17 | 2005-03-17 | Becton, Dickinson And Company | Environments that maintain function of primary liver cells |
MXPA03009902A (es) * | 2003-10-29 | 2005-05-03 | Manuel Francisco Lara Och Jose | Compuestos para reducir la hiperamonemia en pacientes con cirrosis u otras incapacidad para la eliminacion de amonio. |
EP1718667B1 (en) | 2004-02-23 | 2013-01-09 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
CA2565840A1 (en) | 2004-05-06 | 2005-11-17 | Osteologix A/S | High yield and rapid syntheses methods for producing metallo-organic salts |
EP1799759A1 (en) | 2004-08-30 | 2007-06-27 | Lunamed Inc. | 4-phenylbutyric acid controlled-release formulations for therapeutic use |
DE602005019319D1 (de) | 2004-11-26 | 2010-03-25 | Ucl Business Plc | Zusammensetzungen mit ornithin und phenylacetat oder phenylbutyrat zur behandlung von hepatischer enzephalopathie |
SI1948224T1 (sl) | 2005-11-17 | 2014-07-31 | Silverstone Pharma Est. | Stabilna formulacija amorfnih perindoprilnih soli, postopek za njihovo pripravo, posebno industrijsko pripravo, in njihova uporaba pri zdravljenju hipertenzije |
CN201421432Y (zh) * | 2009-02-20 | 2010-03-10 | 山东师范大学 | 一种相干衍射成像处理装置 |
MX2011010262A (es) | 2009-04-03 | 2012-01-25 | Ocera Therapeutics Inc | Fenil acetato de l-ornitina y metodos para elaborar el mismo. |
DK2799067T3 (da) | 2009-06-08 | 2019-06-03 | Ucl Business Plc | Behandling af hjerneinflammation ved anvendelse af L-Ornithin-phenylacetat |
EA028395B1 (ru) | 2010-10-06 | 2017-11-30 | Осера Терапьютикс, Инк. | Способы получения фенилацетата l-орнитина |
-
2011
- 2011-10-05 EA EA201390403A patent/EA028395B1/ru not_active IP Right Cessation
- 2011-10-05 TR TR2019/03978T patent/TR201903978T4/tr unknown
- 2011-10-05 WO PCT/US2011/054983 patent/WO2012048043A1/en active Application Filing
- 2011-10-05 SG SG2013024559A patent/SG189231A1/en unknown
- 2011-10-05 NZ NZ609191A patent/NZ609191A/en unknown
- 2011-10-05 ES ES11831546T patent/ES2720148T3/es active Active
- 2011-10-05 CA CA2813563A patent/CA2813563C/en active Active
- 2011-10-05 US US13/878,146 patent/US8946473B2/en active Active
- 2011-10-05 BR BR112013008054-0A patent/BR112013008054B1/pt active IP Right Grant
- 2011-10-05 KR KR1020137011664A patent/KR101888215B1/ko active IP Right Grant
- 2011-10-05 CN CN201180058441.1A patent/CN103502203B/zh active Active
- 2011-10-05 JP JP2013532925A patent/JP6087284B2/ja active Active
- 2011-10-05 MX MX2013003764A patent/MX360062B/es active IP Right Grant
- 2011-10-05 AU AU2011312042A patent/AU2011312042B2/en not_active Ceased
- 2011-10-05 EP EP11831546.4A patent/EP2625162B1/en active Active
-
2013
- 2013-04-02 IL IL225512A patent/IL225512A/en active IP Right Grant
-
2015
- 2015-01-21 US US14/601,591 patent/US9260379B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
IL225512A (en) | 2017-12-31 |
MX360062B (es) | 2018-10-22 |
AU2011312042B2 (en) | 2015-08-20 |
CA2813563C (en) | 2019-02-26 |
US9260379B2 (en) | 2016-02-16 |
KR20140053807A (ko) | 2014-05-08 |
MX2013003764A (es) | 2013-05-20 |
EP2625162B1 (en) | 2019-03-13 |
WO2012048043A1 (en) | 2012-04-12 |
ES2720148T3 (es) | 2019-07-18 |
CN103502203B (zh) | 2016-09-07 |
NZ609191A (en) | 2015-06-26 |
IL225512A0 (en) | 2013-06-27 |
US20130211135A1 (en) | 2013-08-15 |
TR201903978T4 (tr) | 2019-04-22 |
CA2813563A1 (en) | 2012-04-12 |
EP2625162A1 (en) | 2013-08-14 |
JP6087284B2 (ja) | 2017-03-01 |
BR112013008054A2 (pt) | 2016-06-14 |
JP2013542935A (ja) | 2013-11-28 |
AU2011312042A1 (en) | 2013-05-02 |
EA028395B1 (ru) | 2017-11-30 |
BR112013008054B1 (pt) | 2019-04-09 |
SG189231A1 (en) | 2013-05-31 |
EP2625162A4 (en) | 2014-06-25 |
CN103502203A (zh) | 2014-01-08 |
KR101888215B1 (ko) | 2018-09-20 |
US20150133684A1 (en) | 2015-05-14 |
US8946473B2 (en) | 2015-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201390403A1 (ru) | Способы получения фенилацетата l-орнитина | |
EA201291470A1 (ru) | Замороженное кондитерское изделие | |
BR112015015528A8 (pt) | composição e método para produzir um composto | |
TW201231056A (en) | Metal salt compositions | |
MY166637A (en) | Method for producing ternesite | |
WO2012103279A3 (en) | Methods and compositions for the synthesis of multimerizing agents | |
EA201391274A1 (ru) | Аминохинолины в качестве ингибиторов киназ | |
EA201391180A1 (ru) | Способ получения оптически активных производных дигидробензофурана | |
EA201590887A1 (ru) | Композиция | |
EA201491195A1 (ru) | Способ получения композиции, содержащей галактоолигосахариды | |
EA201391489A1 (ru) | Композиции со сниженной вязкостью | |
WO2014086982A3 (en) | Stable metal compounds, their compositions and methods of their use | |
EA201490756A1 (ru) | Разагилина цитрамид | |
MY166797A (en) | Geopolymer activator composition and geopolymer binder, paste and concrete prepared therewith | |
NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
MX2014002996A (es) | Anticuerpos anti - egfr/anti - igf-1r bisespecificos. | |
CY1118079T1 (el) | Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης | |
MX2013013891A (es) | Sistema y metodo de tratamiento de agua anti-incrustaciones. | |
EA201391056A1 (ru) | Гетероарильные соединения в качестве лигандов 5-htрецептора | |
EA201171466A1 (ru) | Композиция неслеживающейся соли, способ ее получения и использование | |
IN2014MN01671A (ru) | ||
EA201391214A1 (ru) | Композиции, содержащие алкилалкоксисульфонаты, для производства термостабильных пен | |
EA201200820A1 (ru) | Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов | |
TN2015000008A1 (en) | Method for preparing substituted triazolopyridines | |
MX2014007284A (es) | Metodo para etiquetar objetivos intracelulares y extracelulares de leucocitos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |